<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:g-custom="http://base.google.com/cns/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>epm-temp-landing-page</title>
    <link>https://www.epmtherapeutics.com</link>
    <description />
    <atom:link href="https://www.epmtherapeutics.com/feed/rss2" type="application/rss+xml" rel="self" />
    <item>
      <title>epm Therapeutics Announces the Appointment of Kylie O’Keefe to its Board of Directors</title>
      <link>https://www.epmtherapeutics.com/epm-therapeutics-announces-the-appointment-of-kylie-okeefe-to-its-board-of-directors</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/KOK+FINAL+PRESS+RELEASE_Page_1.jpg" alt="epm Therapeutics Announces the Appointment of Kylie O’Keefe to its Board of Directors"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div&gt;&#xD;
  &lt;a target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/KOK+FINAL+PRESS+RELEASE_Page_2.jpg" alt="epm Therapeutics Announces the Appointment of Kylie O’Keefe to its Board of Directors"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png" length="100696" type="image/png" />
      <pubDate>Mon, 11 May 2026 15:20:33 GMT</pubDate>
      <guid>https://www.epmtherapeutics.com/epm-therapeutics-announces-the-appointment-of-kylie-okeefe-to-its-board-of-directors</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>epm Therapeutics Announces Successful Pre-IND Meeting with FDA for EPM301</title>
      <link>https://www.epmtherapeutics.com/blog/epm-therapeutics-announces-successful-pre-ind-meeting-with-fda-for-epm301</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/FINAL+epm+Pre-IND+Successful+Press+Release+v1.png-1.png" alt="epm Therapeutics Secures FDA Pre-IND Meeting
to Advance EPM301 for Prader-Willi Syndrome"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div&gt;&#xD;
  &lt;a target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/FINAL+epm+Pre-IND+Successful+Press+Release+v1.png-2.png" alt="epm Therapeutics Secures FDA Pre-IND Meeting
to Advance EPM301 for Prader-Willi Syndrome"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png" length="100696" type="image/png" />
      <pubDate>Mon, 09 Mar 2026 15:39:40 GMT</pubDate>
      <guid>https://www.epmtherapeutics.com/blog/epm-therapeutics-announces-successful-pre-ind-meeting-with-fda-for-epm301</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>epm Therapeutics Secures FDA Pre-IND Meeting to Advance EPM301 for Prader-Willi Syndrome</title>
      <link>https://www.epmtherapeutics.com/epm-therapeutics-secures-fda-pre-ind-meeting-to-advance-epm301-for-prader-willi-syndrome</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/Final+Press+Release+1-1.png" alt="epm Therapeutics Secures FDA Pre-IND Meeting
to Advance EPM301 for Prader-Willi Syndrome"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div&gt;&#xD;
  &lt;a target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/Final+Press+Release+1-2.png" alt="epm Therapeutics Secures FDA Pre-IND Meeting
to Advance EPM301 for Prader-Willi Syndrome"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png" length="100696" type="image/png" />
      <pubDate>Sat, 10 Jan 2026 16:42:55 GMT</pubDate>
      <guid>https://www.epmtherapeutics.com/epm-therapeutics-secures-fda-pre-ind-meeting-to-advance-epm301-for-prader-willi-syndrome</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Comprehensive Therapeutic Potential of EPM301 for Hyperphagia, Anxiety, and Sleep Disturbances in Prader-Willi Syndrome</title>
      <link>https://www.epmtherapeutics.com/comprehensive-therapeutic-potential-of-epm301-for-hyperphagia-anxiety-and-sleep-disturbances-in-prader-willi-syndrome</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a target="_blank" href="https://irp.cdn-website.com/c388a718/files/uploaded/poster+-2.pdf"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/Slide1.png"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png" length="100696" type="image/png" />
      <pubDate>Mon, 08 Dec 2025 18:04:25 GMT</pubDate>
      <guid>https://www.epmtherapeutics.com/comprehensive-therapeutic-potential-of-epm301-for-hyperphagia-anxiety-and-sleep-disturbances-in-prader-willi-syndrome</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Preclinical Findings Suggest That EPM301 Could Offer Multiple Benefits As A Novel Treatment For Symptoms of Prader-Willi Syndrome</title>
      <link>https://www.epmtherapeutics.com/preclinical-findings-suggest-that-epm301-could-offer-multiple-benefits-as-a-novel-treatment-for-symptoms-of-prader-willi-syndrome</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;a href="https://irp.cdn-website.com/c388a718/files/uploaded/Poster+Pre-Clinical+Findings.pdf" target="_blank"&gt;&#xD;
    &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/Screenshot+2025-12-08+at+12.56.00-PM.png"/&gt;&#xD;
  &lt;/a&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png" length="100696" type="image/png" />
      <pubDate>Mon, 08 Dec 2025 18:00:18 GMT</pubDate>
      <guid>https://www.epmtherapeutics.com/preclinical-findings-suggest-that-epm301-could-offer-multiple-benefits-as-a-novel-treatment-for-symptoms-of-prader-willi-syndrome</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>Enhanced Bioavailability and Therapeutic Potential of EPM301, a Novel Cannabidiol Analogue, in the treatment of Prader-Willi Syndrome</title>
      <link>https://www.epmtherapeutics.com/enhanced-bioavailability-and-therapeutic-potential-of-epm301-a-novel-cannabidiol-analogue-in-the-treatment-of-prader-willi-syndrome</link>
      <description />
      <content:encoded>&lt;div&gt;&#xD;
  &lt;img src="https://irp.cdn-website.com/c388a718/dms3rep/multi/Poster_Download-5ed6e728.png" alt="Poster: Enhanced bioavailability and therapeutic potential of EPM301, a novel cannabidiol analogue for treating Prader-Willi Syndrome."/&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png" length="100696" type="image/png" />
      <pubDate>Thu, 05 Jun 2025 12:55:35 GMT</pubDate>
      <guid>https://www.epmtherapeutics.com/enhanced-bioavailability-and-therapeutic-potential-of-epm301-a-novel-cannabidiol-analogue-in-the-treatment-of-prader-willi-syndrome</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/c388a718/dms3rep/multi/Website+PNGs+%281%29.png">
        <media:description>main image</media:description>
      </media:content>
    </item>
  </channel>
</rss>
